CIBC Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Hold
4,148
﹤0.01% 997
2026
Q1
$357K Hold
4,148
﹤0.01% 905
2025
Q4
$362K Buy
4,148
+581
+16% +$44.1K ﹤0.01% 892
2025
Q3
$204K Hold
3,567
﹤0.01% 1151
2025
Q2
$211K Hold
3,567
﹤0.01% 1091
2025
Q1
$261K Buy
3,567
+80
+2% +$6.61K ﹤0.01% 928
2024
Q4
$288K Buy
3,487
+175
+5% +$13.8K ﹤0.01% 904
2024
Q3
$237K Buy
3,312
+119
+4% +$8.4K ﹤0.01% 992
2024
Q2
$219K Buy
+3,193
New +$191K ﹤0.01% 969
2022
Q4
Sell
-3,723
Closed -$222K 1141
2022
Q3
$222K Hold
3,723
﹤0.01% 1029
2022
Q2
$209K Sell
3,723
-270
-7% -$17.7K ﹤0.01% 1092
2022
Q1
$295K Hold
3,993
﹤0.01% 1074
2021
Q4
$288K Sell
3,993
-5
-0.1% -$363 ﹤0.01% 1109
2021
Q3
$306K Buy
3,998
+337
+9% +$27.1K ﹤0.01% 1010
2021
Q2
$284K Hold
3,661
﹤0.01% 1033
2021
Q1
$226K Sell
3,661
-126
-3% -$7.98K ﹤0.01% 1156
2020
Q4
$247K Buy
+3,787
New +$218K ﹤0.01% 1003
2020
Q1
Sell
-3,694
Closed -$218K 1078
2019
Q4
$218K Buy
+3,694
New +$201K ﹤0.01% 1024

Other funds holding GMED

CIBC Asset Management's GMED Position: Q2 2026 in Review

CIBC Asset Management held its Globus Medical (GMED) position steady in Q2 2026 at 4,148 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

CIBC Asset Management first reported a position in GMED in Q4 2019 and has held it in 18 quarters since. The position peaked at $362K in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • CIBC Asset Management held 4,148 shares of Globus Medical worth $328K as of Q2 2026.
  • CIBC Asset Management left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #997 holding.
  • CIBC Asset Management first reported a position in Globus Medical in Q4 2019 and has held it in 18 quarters since.
  • CIBC Asset Management's Globus Medical position peaked at $362K in Q4 2025.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.